# Green Dot Bioplastics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/green-dot-bioplastics

- Industry: Materials
- Headquarters: Emporia, US
- Website: www.greendotbioplastics.com
- Total disclosed funding: $6.5M
- Latest round: Series A (Feb 6, 2019)
- Investors on record: 3

## About

Green Dot Bioplastics LLC specializes in developing innovative bioplastic materials that provide sustainable alternatives to conventional plastics, addressing environmental concerns through eco-friendly solutions.Founded in 2011 in Emporia, US, Green Dot Bioplastics LLC produces bioplastics that offer compostable solutions. The company raised USD 6.50 mn in Series A funding in February 2019, led by Fulcrum Global Capital and joined by Innovation in Motion and Open Prairie Ventures. The CEO, David Sonn, co-founded the company alongside Mark Mahoney, focusing on sustainable product development.Green Dot Bioplastics specializes in producing a diverse range of bioplastic materials designed to address the increasing demand for sustainable alternatives to traditional plastics. The company's core offerings include the Terratek® BD line of rigid compostable materials, created from proprietary starch-based blends, and the Terratek® FX line of compostable elastomers that combine strength and flexibility with an appealing soft touch. Additionally, Green Dot produces Terratek® WC/SC biocomposite materials, made from renewable sources like wood, starch, or hemp, catering to eco-friendly product designs. Their bioplastics serve various end users, including manufacturers in the food packaging sector and companies focused on sustainability initiatives, enhancing compostability and reducing reliance on virgin plastics. Green Dot's products are marketed primarily in North America and Europe, where regulatory and consumer pressures drive demand for eco-friendly materials.Green Dot Bioplastics generates revenue through B2B transactions, providing its bioplastic products directly to manufacturers and brands involved in sustainable packaging and product design. The company's revenue model typically involves bulk sales, where clients purchase quantities of Terratek® materials for integration into their own product lines. Pricing structures vary based on the specific materials and formulations chosen, with particular emphasis on flagship offerings like Terratek® BD and Terratek® FX. Clients are often engaged in long-term partnerships, reflecting a commitment to sustainable practices and the use of bioplastics in commercial applications. The company also collaborates with retailers and wholesalers, facilitating the distribution of its materials to a broader market that values environmentally responsible products.Green Dot Bioplastics plans to leverage the recent funding of USD 6.50 mn raised in Series A funding to enhance its product development and market reach. The company is focusing on expanding its Terratek® product lines with new formulations aimed at increasing performance and applications in various sectors. Additionally, plans are underway to enter new markets in Asia by 2025, capitalizing on the rising demand for sustainable materials. This strategic expansion aims to increase product availability and support global sustainability initiatives.

## Funding rounds

- Series A, Feb 6, 2019, $6.5M — Open Prairie, Fulcrum Global Capital, Innovation in Motion

## Investors

- Open Prairie (https://capitalatlas.ai/funds/open-prairie) — Series A
- Fulcrum Global Capital (https://capitalatlas.ai/funds/fulcrum-global-capital) — Series A
- Innovation in Motion (https://capitalatlas.ai/funds/innovation-in-motion) — Series A